Alignment Healthcare, Inc. (ALHC) Q4 2025 Earnings Call Transcript

Understand this faster with AI
SA Transcripts158.7K FollowersFollow5ShareSaveCommentsQ4: 2026-02-26 Earnings SummaryPlay CallPlay CallPR10-KEPS of -$0.00 beats by $0.08 | Revenue of $1.01B (44.43% Y/Y) beats by $8.16M Alignment Healthcare, Inc. (ALHC) Q4 2025 Earnings Call February 26, 2026 5:00 PM EST Company Participants John Kao - Founder, CEO & DirectorJames Head - Chief Financial Officer Conference Call Participants Hua Ha - Robert W. Baird & Co. Incorporated, Research DivisionJohn Stansel - JPMorgan Chase & Co, Research DivisionMatthew Gillmor - KeyBanc Capital Markets Inc., Research DivisionCraig Jones - BofA Securities, Research DivisionRyan Langston - TD Cowen, Research DivisionBenjamin Mayo - Leerink Partners LLC, Research DivisionJessica Tassan - Piper Sandler & Co., Research DivisionJonathan Yong - UBS Investment Bank, Research DivisionJohn Ransom - Raymond James & Associates, Inc., Research DivisionRaj Kumar - Stephens Inc., Research Division Presentation Operator Good afternoon, and welcome to Alignment Healthcare's Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] And please note that this event is being recorded. Leading today's call is John Kao, Founder and CEO; and Jim Head, Chief Financial Officer. Before we begin, we would like to remind you that certain statements made during this call will be forward-looking statements as defined by the Private Securities Litigation Reform Act. These forward-looking statements are subject to various risks and uncertainties and reflect our current expectations based on our beliefs, assumptions and information currently available to us. Descriptions of some of the factors that could cause actual results to differ materially from these forward-looking statements are discussed in more detail in our filings with the SEC, including the Risk Factors sections of our annual report on Form 10-K for the fiscal year ended December 31, 2025. Although we believe our expectations are reasonable, we undertake no obligation to revise any statements to reflect changes that occur after this call. In addition, please note that the company will be discussing certain non-GAAP financial measures that we believe are important in evaluating performance. Details on the relationship between
Tags
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
